These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 8565286)
1. Prevalence of hepatitis C in patients with primary antibody deficiency. Webster AD; Brown D; Franz A; Dusheiko G Clin Exp Immunol; 1996 Jan; 103(1):5-7. PubMed ID: 8565286 [TBL] [Abstract][Full Text] [Related]
2. [Laboratory markers in hepatitis C virus infection in patients with antibody formation disorders treated with immunoglobulin preparations]. Litzman J; Pejcochová J; Lokaj J Vnitr Lek; 1996 May; 42(5):324-6. PubMed ID: 8768290 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection in Italian patients with hypogammaglobulinemia. Quinti I; Pandolfi F; Paganelli R; Giovannetti A; Sacco G; Oliva A; Aiuti F Clin Ther; 1996; 18 Suppl B():96-107. PubMed ID: 8930447 [TBL] [Abstract][Full Text] [Related]
4. Unusual course of the hepatitis C virus infection in one patient diagnosed of common variable immunodeficiency. Múñoz FJ; de la Calle A; Giménez MJ; González J; Conde J Allergol Immunopathol (Madr); 1995; 23(6):263-6. PubMed ID: 8579003 [TBL] [Abstract][Full Text] [Related]
5. European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries. Quinti I; Pierdominici M; Marziali M; Giovannetti A; Donnanno S; Chapel H; Bjorkander J; Aiuti F; Clin Immunol; 2002 Sep; 104(3):231-6. PubMed ID: 12217332 [TBL] [Abstract][Full Text] [Related]
6. A prospective controlled crossover trial of a new heat-treated intravenous immunoglobulin. Zuhrie SR; Webster AD; Davies R; Fay AC; Wallington TB Clin Exp Immunol; 1995 Jan; 99(1):10-5. PubMed ID: 7813100 [TBL] [Abstract][Full Text] [Related]
7. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. Rossi G; Tucci A; Cariani E; Ravaggi A; Rossini A; Radaeli E Blood; 1997 Aug; 90(3):1309-14. PubMed ID: 9242566 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. Bjøro K; Frøland SS; Yun Z; Samdal HH; Haaland T N Engl J Med; 1994 Dec; 331(24):1607-11. PubMed ID: 7526215 [TBL] [Abstract][Full Text] [Related]
9. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Jonas MM; Baron MJ; Bresee JS; Schneider LC Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620 [TBL] [Abstract][Full Text] [Related]
10. HCV infection in patients with primary defects of immunoglobulin production. Quinti I; Pandolfi F; Paganelli R; el Salman D; Giovannetti A; Rosso R; Oliva A; Rainaldi L; Aiuti F Clin Exp Immunol; 1995 Oct; 102(1):11-6. PubMed ID: 7554376 [TBL] [Abstract][Full Text] [Related]
19. Carimune NF Liquid is a safe and effective immunoglobulin replacement therapy in patients with primary immunodeficiency diseases. Berger M; Cunningham-Rundles C; Bonilla FA; Melamed I; Bichler J; Zenker O; Ballow M J Clin Immunol; 2007 Sep; 27(5):503-9. PubMed ID: 17479360 [TBL] [Abstract][Full Text] [Related]
20. Infection by hepatitis C virus through contaminated intravenous immune globulin: results of a prospective national inquiry in France. Lefrère JJ; Loiseau P; Martinot-Peignoux M; Mariotti M; Ravera N; Thauvin M; Marcellin P; Janot C Transfusion; 1996 May; 36(5):394-7. PubMed ID: 8693501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]